Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: September 20, 2017
| Title: | Technetium-99m labeled peptides for imaging having a single thiol containing moiety |
| Abstract: | The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind Tc-99m and which can be targeted to specific sites within a mammalian body. |
| Inventor(s): | Dean; Richard T. (Bedford, NH), McBride; William (Manchester, NH), Buttram; Scott (Derry, NH) |
| Assignee: | Diatide, Inc. (Londonderry, NH) |
| Filing Date: | Jun 06, 1995 |
| Application Number: | 08/471,741 |
| Claims: | 1. A radioactively-labeled peptide for imaging a target site within a mammalian body, comprising: a) a specific binding peptide having between 4 and 100 amino acid residues that concentrates at said target site; b) a complexing group covalently linked to the specific binding peptide, said group comprising a single thiol moiety having a formula: wherein A is H or HOOC B is H, SH or NHR", where R" is H or lower alkyl; X is SH or NHR", where R" is H or lower alkyl; R and R' are independently H or lower alkyl; n is 0, 1,or 2; and where B is NHR", X is SH and n is 1 or 2; where X is NHR", B is SH and n is 1 or 2; where B is H, A is HOOC, X is SH and n is 0 or 1; said group further comprising a dipeptide covalently linked to A when A is COOH, or to B when B is NH.sub.2, or to X when X is NH.sub.2 ; and c) a radioactive isotope complexed to the complexing group. 2. The complex of claim 1, wherein the isotope is technetium-99m. 3. The complex of claim 2 formed by reacting technetium-99m and a reducing agent with a peptide comprising: a) a specific binding peptide having between 4 and 100 amino acid residues that concentrates at a target site within a mammalian body; and b) a complexing group covalently linked to the specific binding peptide, said group comprising a single thiol moiety having a formula: wherein A is H or HOOC B is H, SH or NHR", where R" is H or lower alkyl; X is SH or NHR", where R" is H or lower alkyl; R and R' are independently H or lower alkyl; n is 0, 1, or 2; and where B is NHR", X is SH and n is 1 or 2; where X is NHR", B is SH and n is 1 or 2; where B is H, A is HOOC, X is SH and n is 0 or 1; said group further comprising a dipeptide covalently linked to A when A is COOH, or to B when B is NH.sub.2, or to X when X is NH.sub.2. 4. The complex of claim 3, wherein the reducing agent is a dithionite ion, a stannous ion, or a solid-phase reducing agent. 5. The complex of claim 2 formed by ligand exchange of a prereduced technetium-99m complex with a peptide comprising a) a specific binding peptide having between 4 and 100 amino acid residues that concentrates at a target site within a mammalian body; and b) a complexing group covalently linked to the specific binding peptide, said group comprising a single thiol moiety having a formula: wherein A is H or HOOC B is H, SH or NHR", where R" is H or lower alkyl; X is SH or NHR", where R" is H or lower alkyl; R and R' are independently H or lower alkyl; n is 0, 1,or2; and where B is NHR", X is SH and n is 1 or 2; where X is NHR", B is SH and n is 1 or 2; where B is H, A is HOOC, X is SH and n is 0 or 1; said group further comprising a dipeptide covalently linked to A when A is COOH, or to B when B is NH.sub.2, or to X when X is NH.sub.2. |
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,681 others who get our Drug Patent Expiration Alerts:
